Patrick Affeldt

Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients

R. Müller, T. Benzing, G. Steger, 2022, Viruses.

Combined Therapy with Intravenous Immunoglobulins, Letermovir and (Val-)Ganciclovir in Complicated Courses of CMV-Infection in Transplant Recipients

R. Kaiser, R. Müller, D. Stippel, 2021, Microorganisms.

CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality.

R. Kaiser, G. Steger, U. Holtick, 2023, Bone Marrow Transplantation.

Immune Responses to SARS-CoV-2 Infection and Vaccination in Dialysis Patients and Kidney Transplant Recipients

R. Müller, T. Benzing, D. Stippel, 2021, Microorganisms.

Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation

R. Kaiser, T. Benzing, D. Stippel, 2021, Immunity, inflammation and disease.

Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool

L. Gieselmann, H. Gruell, Christoph Kreer, 2023, Science Immunology.

Five‐year single‐center analysis of cytomegalovirus viremia in kidney transplant recipients and possible implication for novel prophylactic therapy approaches

F. Koehler, E. Knops, E. Heger, 2024, Transplant infectious disease : an official journal of the Transplantation Society.